The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expression

INTRODUCTION: Targeting CD74 as the invariant chain of major histocompatibility complexes (MHC) became possible by the availability of a specific humanized monoclonal antibody, milatuzumab, which is under investigation in patients with hematological neoplasms. CD74 has been reported to regulate chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Frölich, Daniela, Blaβfeld, Daniela, Reiter, Karin, Giesecke, Claudia, Daridon, Capucine, Mei, Henrik E, Burmester, Gerd R, Goldenberg, David M, Salama, Abdulagabar, Dörner, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446420/
https://www.ncbi.nlm.nih.gov/pubmed/22404985
http://dx.doi.org/10.1186/ar3767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446420/
https://www.ncbi.nlm.nih.gov/pubmed/22404985
http://dx.doi.org/10.1186/ar3767

Ejemplares similares